| Isotopic characteristics of Indian precipitation B Kumar, SP Rai, US Kumar, SK Verma, P Garg, SVV Kumar, R Jaiswal, ... Water Resources Research 46 (12), 2010 | 235 | 2010 |
| Filamentous bacteriophage: A prospective platform for targeting drugs in phage-mediated cancer therapy P Garg JOURNAL OF CANCER &THERAPEUTICS 15 (8), 1-10, 2019 | 25 | 2019 |
| Recent Advancement in Breast Cancer Research: Insights from Model Organisms—Mouse Models to Zebrafish SS Singhal, R Garg, A Mohanty, P Garg, SK Ramisetty, T Mirzapoiazova, ... Cancers 15 (11), 2961, 2023 | 22 | 2023 |
| Prognostic significance of natural products against multidrug tumor resistance P Garg, R Garg, D Horne, S Awasthi, R Salgia, SS Singhal Cancer Letters 557, 216079, 2023 | 17 | 2023 |
| Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancers P Garg, A Mohanty, S Ramisetty, P Kulkarni, D Horne, E Pisick, R Salgia, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 189026, 2023 | 16 | 2023 |
| Selective Preference of Antibody Mimetics over Antibody, as Binding Molecules, for Diagnostic and Therapeutic Applications in Cancer Therapy P Garg Biointerface Res. Appl. Chem 11, 10765-10775, 2021 | 11 | 2021 |
| Conjugation of antibodies with radiogold nanoparticles, as an effector targeting agents in Radio-bio conjugate cancer therapy: Optimized labeling and biodistribution results. P Garg, DK Hazra Ind. J. Nucl Med 32 (4), 302-309, 2017 | 10 | 2017 |
| Rhizospheric Bacillus spp. Exhibit Miticidal Efficacy against Oligonychus coffeae (Acari: Tetranychidae) of Tea P Bora, S Gogoi, MV Deshpande, P Garg, RP Bhuyan, N Altaf, N Saha, ... Microorganisms 11 (11), 2691, 2023 | 9 | 2023 |
| The innate effects of plant secondary metabolites in preclusion of gynecologic cancers: Inflammatory response and therapeutic action P Garg, S Awasthi, D Horne, R Salgia, SS Singhal Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1878 (4), 188929, 2023 | 7 | 2023 |
| Experimental Spectroscopic, DFT, Molecular Docking, and Molecular Dynamics Simulation Investigations on m-Phenylenediamine (Monomer and Trimer) A Fatima, A Ali, R Rajan, I Verma, S Muthu, N Siddiqui, P Garg, S Javed Polycyclic Aromatic Compounds 43 (10), 8599-8631, 2023 | 5 | 2023 |
| Pretargeting in radiobiocojugate therapy: with reference to Rhenium, Gold and Lutetium as candidate therapy isotopes. Garg, P., Hazra, D.K. Indian journal of nuclear medicine 22 (1), 1-8, 2007 | 5 | 2007 |
| Emerging Biomarkers and Molecular Targets for Precision Medicine in Cervical Cancer P Garg | 5* | |
| Nanoengineering Solutions for Cancer Therapy: Bridging the Gap Between Clinical Practice and Translational Research P Garg | 3 | 2024 |
| Regression of ovarian cancer xenografts by depleting or inhibiting RLIP SK Ramisetty, P Garg, A Mohanty, T Mirzapoiazova, E Yue, E Wang, ... Biochemical Pharmacology 217, 115847, 2023 | 2 | 2023 |
| Antiviral drugs and vaccines for omicron variant: A focused review N Garg, AS Kunamneni, P Garg, S Sharma, D Sharma, A Kunamneni Canadian Journal of Infectious Diseases and Medical Microbiology 2023 (1 …, 2023 | 2 | 2023 |
| Radiobioconjugate targeted therapy in cancer, using radiolabeled mediated biological analogs: Desired qualities and selective targeting approach P Garg Biomedical and Biotechnology Research Journal (BBRJ) 6 (1), 40-49, 2022 | 2 | 2022 |
| The New Variants of Corona-Virus Mutations: An Understanding to Their Infectivity, Immunological Tolerance and Vaccine Efficacy P Garg Nano Life 11 (03), 2130010, 2021 | 2 | 2021 |
| Spectroscopic, Computational, Molecular Docking and Dynamics Simulations Studies of 4-Amino-3-hydroxyNaphthalene-1-Sulfonic Acid (ANSA) HK Pathan, A Fatima, P Garg, S Muthu, A Yadav, N Siddiqui, M Ali, ... Polycyclic Aromatic Compounds 44 (6), 3787-3806, 2024 | 1 | 2024 |
| Pretargeting Articulation for Improving the Deliverance of Injected Dose to the Tumor: An Evaluation of: In vivo: Study for Enhanced Tumor Uptake P Garg Biomedical and Biotechnology Research Journal (BBRJ) 6 (3), 387-393, 2022 | 1 | 2022 |
| Optimization of antibody constructs for Radioimmuno therapy: Evaluating multi Fab constructs. PG “Padmallika K. Hazra, Daya Hazra, Arun Gupta Journal Nuclear Medicine (JNM) 47 (supplement-1), 414-416, 2006 | 1* | 2006 |